Trauma News and Research

RSS

Researchers report promising new approach to treat diabetic wounds, bed sores

Loyola University Health System researchers are reporting on a promising new approach to treating diabetic wounds, bed sores, chronic ulcers and other slow-to-heal wounds.

8 Feb 2011

Motorcycle helmets reduce spine injuries after collisions

Motorcycle helmets, long known to dramatically reduce the number of brain injuries and deaths from crashes, appear to also be associated with a lower risk of cervical spine injury, new research from Johns Hopkins suggests.

8 Feb 2011

Hematopoietic stem cells are less fixed, more flexible than previously thought: Study

The bone marrow stem cells responsible for generating new blood cells are less fixed and more flexible than previously thought, according to a paper published online on February 7 in the Journal of Experimental Medicine.

8 Feb 2011

Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

Viking Systems, a leading worldwide developer, manufacturer and marketer of 2D and 3D visualization solutions for complex minimally invasive surgery, today announced that it has retained Porter, LeVay & Rose, Inc., to advise the Company on its investor relations initiatives.

7 Feb 2011

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Integra LifeSciences Holdings Corp announced today the launch of Integra Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra Allograft Cancellous Sponge allow it to absorb fluids like saline, blood or bone marrow aspirate.

7 Feb 2011

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

EpiCept Corporation today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy. EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

7 Feb 2011

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

Accidental damage to thin or buried nerves during surgery can have severe consequences, from chronic pain to permanent paralysis. Scientists at the University of California, San Diego School of Medicine may have found a remedy: injectable fluorescent peptides that cause hard-to-see peripheral nerves to glow, alerting surgeons to their location even before the nerves are encountered.

6 Feb 2011

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

5 Feb 2011

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Roche announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify parvovirus B19 and detect hepatitis A virus (HAV) simultaneously in one assay in human plasma.

5 Feb 2011

Inspiration presents IB1001 PK data for treatment of hemophilia B

Inspiration Biopharmaceuticals, today presented pharmacokinetic data on its lead product, IB1001, a recombinant factor IX for the treatment and prevention of bleeding in individuals with hemophilia B.

3 Feb 2011

Concert and WRAIR enter CRADA to evaluate novel compound for seizure protection associated with TBI

Concert Pharmaceuticals, Inc. today announced that it has entered into a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research. The CRADA will allow the WRAIR to conduct preclinical testing on a novel compound derived from Concert's DCE Platform™ (deuterated chemical entity platform) for seizure protection associated with traumatic brain injury, a major public health concern.

3 Feb 2011

Cervical cancer screening rates are quite low among older, poorer South Asians

Immigrant women in Ontario are not screened for cervical cancer as often as native-born Canadians, with the lowest rates being among older, poorer South Asians, new research shows.

3 Feb 2011

Study finds contradictory role of RIP1 protein in the liver during sepsis

Researchers from Rhode Island Hospital have identified a protein that plays a dual role in the liver during sepsis. The protein, known as RIP1, acts both as a "death switch" and as a pro-survival mechanism. The ability to identify the triggers for these functions may play a key role in treating sepsis in the future. The study is published online in advance of print in the journal Shock.

3 Feb 2011

Researchers discover potential vaccine capable of reducing H. pylori colonization

A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori -- a known cause of gastritis, ulcer disease and cancer.

2 Feb 2011

Study: Simple sideline test can accurately detect concussions in athletes

A simple test performed at the sideline of sporting events can accurately detect concussions in athletes, according to study by researchers at the University of Pennsylvania School of Medicine. Current sideline tests can leave a wide amount a brain function untested following concussion.

2 Feb 2011

Effective methods to change physician behavior and improve compliance to guidelines

When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.

2 Feb 2011

DARA BioSciences' KRN5500 Phase 2 study in advanced cancer selected for presentation at ADEPT 2011

The Company announced that the University of Rochester in concert with ADEPT has selected the study results from the KRN5500 Phase 2 study to be presented at its March 25-26, 2011 conference. The presentation is entitled, "Management of Placebo Response in a Randomized Trial of KRN5500 in Patients with Neuropathic Pain and Cancer."

2 Feb 2011

Study identifies effects of multiple previous concussions on high school students

A previous study of ex-NFL players showed that the damage caused by concussions occurs in the same region of the brain as damage caused by Alzheimer's disease, resulting in increased concern over post-concussion related injuries and trauma of athletes. Philip Schatz Ph.D., professor of psychology, and his associates recently published a study in Neurosurgery that identifies potentially enduring effects of multiple previous concussions on high school students.

2 Feb 2011

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

On the final day of the two-day African Union Summit taking place in Addis Ababa, Ethiopia, U.N. Secretary-General Ban Ki-moon on Monday called for greater efforts to reduce sexual violence, particularly during armed conflicts, Ezega.com reports.

2 Feb 2011

Raytheon, Baptist sign agreement to deliver SMART training for health care systems

Raytheon Professional Services LLC, a subsidiary of Raytheon Company, and Baptist Health have signed an agreement to deliver Synergistic Medical and Resource Team training to health care systems.

2 Feb 2011

Trauma News and Research

Researchers report promising new approach to treat diabetic wounds, bed sores

Motorcycle helmets reduce spine injuries after collisions

Hematopoietic stem cells are less fixed, more flexible than previously thought: Study

Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

Dermatologists urge athletes to be aware of most common skin infections

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Inspiration presents IB1001 PK data for treatment of hemophilia B

Concert and WRAIR enter CRADA to evaluate novel compound for seizure protection associated with TBI

Cervical cancer screening rates are quite low among older, poorer South Asians

Study finds contradictory role of RIP1 protein in the liver during sepsis

Researchers discover potential vaccine capable of reducing H. pylori colonization

Study: Simple sideline test can accurately detect concussions in athletes

Effective methods to change physician behavior and improve compliance to guidelines

DARA BioSciences' KRN5500 Phase 2 study in advanced cancer selected for presentation at ADEPT 2011

Study identifies effects of multiple previous concussions on high school students

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

Raytheon, Baptist sign agreement to deliver SMART training for health care systems

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News